Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
TXNM Energy, Inc.
13G
TXNM · 69349H107
|
5.9% |
8/14/2026
Event 6/30/2026
|
|||
| Pentwater Capital Management LP | 5.9% | ||||
| Matthew Halbower | 5.9% | ||||
|
Masimo Corp
13G/A
MASI · 574795100
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Amc Entertainment Holdings, Inc.
13G/A
AMC · 00165C302
|
0.3% |
8/14/2026
Event 6/30/2026
|
|||
| Pentwater Capital Management LP | 0.3% | ||||
| Matthew Halbower | 0.3% | ||||
|
Core Scientific, Inc.
13G/A
CORZ · 21874A106
|
0.4% |
8/14/2026
Event 6/30/2026
|
|||
| Pentwater Capital Management LP | 0.4% | ||||
| Matthew Halbower | 0.4% | ||||
|
Centessa Pharmaceuticals plc
13G/A
CNTA · 152309100
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Organon & Co.
13G
OGN · 68622V106
|
6.9% |
8/14/2026
Event 6/30/2026
|
|||
| Pentwater Capital Management LP | 6.9% | ||||
| Matthew Halbower | 6.9% | ||||
|
Caesars Entertainment, Inc.
13G
CZR · 12769G100
|
5.6% |
8/14/2026
Event 6/30/2026
|
|||
| Pentwater Capital Management LP | 5.6% | ||||
| Matthew Halbower | 5.6% | ||||
|
Dayforce, Inc.
13G/A
DAY · 15677J108
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
CyberArk Software Ltd.
13G/A
CYBR · M2682V108
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Surgery Partners, Inc.
13G/A
SGRY · 86881A100
|
9.7% |
5/15/2026
Event 3/31/2026
|
|||
| Pentwater Capital Management LP | 9.7% | ||||
| Matthew Halbower | 9.7% | ||||
|
The GEO Group Inc.
13G
GEO · 36162J106
|
7.2% |
5/15/2026
Event 3/31/2026
|
|||
| Pentwater Capital Management LP | 7.2% | ||||
| Matthew Halbower | 7.2% | ||||
|
Electronic Arts Inc.
13G
EA · 285512109
|
5.1% |
5/15/2026
Event 3/31/2026
|
|||
| Pentwater Capital Management LP | 5.1% | ||||
| Matthew Halbower | 5.1% | ||||
|
Avis Budget Group, Inc.
13G/A
CAR · 053774105
|
7.3% |
5/7/2026
Event 4/30/2026
|
|||
| Pentwater Capital Management LP | 7.3% | ||||
| Matthew Halbower | 7.3% | ||||
|
Spirit AeroSystems Holdings, Inc.
13G/A
SPR · 848574109
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
DigitalBridge Group, Inc.
13G
DBRG · 25401T603
|
6.3% |
2/17/2026
Event 12/31/2025
|
|||
| Pentwater Capital Management LP | 6.3% | ||||
| Matthew Halbower | 6.3% | ||||
|
Verona Pharma plc
13G
VRNA · 925050106
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
89bio, Inc.
13G
ETNB · 282559103
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Amedisys Inc
13G/A
AMED · 023436108
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Skechers USA Inc
13G/A
SKX · 830566105
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Blueprint Medicines Corp
13G
BPMC · 09627Y109
|
6.0% |
8/14/2025
Event 6/30/2025
|
|||
| Pentwater Capital Management LP | 6.0% | ||||
| Matthew Halbower | 6.0% | ||||
|
United States Steel Corp
13G/A
X · 912909108
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Verve Therapeutics, Inc.
13G
VERV · 92539P101
|
7.5% |
8/14/2025
Event 6/30/2025
|
|||
| Pentwater Capital Management LP | 7.5% | ||||
| Matthew Halbower | 7.5% | ||||
|
Smartsheet Inc
13G/A
SMAR · 83200N103
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Vizio Holding Corp.
13G/A
VZIO · 92858V101
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||
|
Poseida Therapeutics, Inc.
13D/A
PSTX · 73730P108
|
0% |
1/13/2025
Event 1/8/2025
|
|||
| Pentwater Capital Management LP | 0% | ||||
| Matthew Halbower | 0% | ||||